Skip to main content

The Motor System and Narcolepsy: Periodic Leg Movements and Restless Legs Syndrome

  • Chapter
  • First Online:
Book cover Narcolepsy
  • 1785 Accesses

Abstract

Restless legs syndrome (RLS) is a sensorimotor disorder with the cardinal symptoms consisting of an urge to move the legs because of unpleasant sensations, appearing during rest or inactivity, worsening at evening or during the night, which are partially or totally recovered by movement [1]. Depending on the severity and frequency of the symptoms, RLS is often associated with insomnia and an impairment of quality of life [2]. Periodic leg movements (PLM) during sleep may be observed in more than 80% of RLS patients [3]. The pathogenesis of RLS is still unknown, but there are several pieces of evidence that advert to a possible dysfunction of descending dopaminergic neurons from the hypothalamic A11 region to the intermediolateral and dorsal spinal gray matter [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101–19.

    Article  PubMed  Google Scholar 

  2. Allen RP. Restless legs syndrome effects on quality of life. In: Ondo WG, editor. Restless legs syndrome diagnosis and treatment. New York: Informa Healthcare; 2007. p. 199–203.

    Google Scholar 

  3. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12(1):61–5.

    Article  PubMed  CAS  Google Scholar 

  4. Rye DB. Parkinson’s disease and RLS: the dopaminergic bridge. Sleep Med. 2004;5(3):317–28.

    Article  PubMed  Google Scholar 

  5. Kvernmo T, Hartter S, Burger E. A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. Clin Ther. 2006;28(8):1065–78.

    Article  PubMed  CAS  Google Scholar 

  6. Clemens S, Hochman S. Conversion of the modulatory actions of dopamine on spinal reflexes from depression to facilitation in D3 receptor knock-out mice. J Neurosci. 2004;24(50):11337–45.

    Article  PubMed  CAS  Google Scholar 

  7. Inami Y, Horiguchi J, Nishimatsu O, Sasaki A, Sukegawa T, Katagiri H, et al. A polysomnographic study on periodic limb movements in patients with restless legs syndrome and neuroleptic-induced akathisia. Hiroshima J Med Sci. 1997;46(4):133–41.

    PubMed  CAS  Google Scholar 

  8. Chaudhuri KR. Iron and restless legs syndrome: the story unfolds. Sleep Med. 2006;7(5):395–6.

    Article  PubMed  Google Scholar 

  9. Michaud M, Dumont M, Selmaoui B, Paquet J, Fantini ML, Montplaisir J. Circadian rhythm of restless legs syndrome: relationship with biological markers. Ann Neurol. 2004;55(3):372–80.

    Article  PubMed  CAS  Google Scholar 

  10. Manconi M, Ferri R, Zucconi M, Oldani A, Fantini ML, Castronovo V, et al. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements. Sleep Med. 2007;8(5):491–7.

    Article  PubMed  Google Scholar 

  11. Montplaisir J, de Champlain J, Young SN, et al. Narcolepsy and idiopathic hypersomnia: biogenic amines and related compounds in CSF. Neurology. 1982;32:1299–302.

    Article  PubMed  CAS  Google Scholar 

  12. Aldrich MS, Hollingeswoth Z, Penney JB. Dopamine-receptor autoradiography of human narcoleptic brain. Neurology. 1992;42:410–5.

    Article  PubMed  CAS  Google Scholar 

  13. Kish SJ, Mamelak M, Slimovitch C, et al. Brain neurotransmitter changes in human narcolepsy. Neurology. 1992;42:229–34.

    Article  PubMed  CAS  Google Scholar 

  14. Rinne JO, Hublin C, Partinen M, et al. Positron emission tomography study of human narcolepsy: no increase in striatal dopamine D2 receptors. Neurology. 1995;45:1735–8.

    Article  PubMed  CAS  Google Scholar 

  15. Hublin C, Launes J, Nikkinen P, Partinen M. Dopamine D2-receptors in human narcolepsy: a SPECT study with 125I-IBZM. Acta Neurol Scand. 1995;90:186–9.

    Article  Google Scholar 

  16. Rinne JO, Hublin C, Nagren K, Helenius H, Partinen M. Unchanged striatal dopamine transporter availability in narcolepsy: a PET study with [11C]-CFT. Acta Neurol Scand. 2004;109:52–5.

    Article  PubMed  CAS  Google Scholar 

  17. Honda K, Riehl J, Mignot E, Nishino S. Dopamine D3 agonists into the substratia nigra aggravates cataplexy but does not modify sleep. Neuroreport. 1999;10:3111–8.

    Article  PubMed  CAS  Google Scholar 

  18. Okura M, Riehl J, Mignot E, Nishino S. Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy. Neuropsychopharmacology. 2000;23:528–38.

    Article  PubMed  CAS  Google Scholar 

  19. Miller JD, Farber J, Gatz P, Roffwarg H, German DC. Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and waking in the rat. Brain Res. 1983;273:133–41.

    Article  PubMed  CAS  Google Scholar 

  20. Piercey MF, Hoffmann WE, Smith MW, Hyslop DK. Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists. Eur J Pharmacol. 1996;312:35–44.

    Article  PubMed  CAS  Google Scholar 

  21. Nishino S, Honda K, Riehl J, Mignot E. Extracellular single unit recordings of dopaminergic neurons in the ventral tegmental area in narcoleptic dobermans. Sleep. 2000;23(S2):A1a.

    Google Scholar 

  22. Taheri S, Zeitzer JM, Mignot E. The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu Rev Neurosci. 2002;25:283–313.

    Article  PubMed  CAS  Google Scholar 

  23. Hagan JJ, Leslie RA, Patel S, et al. Orexin A activates locus coeruleus cell firing and increases arousal in rat. Proc Natl Acad Sci USA. 1999;96:10911–6.

    Article  PubMed  CAS  Google Scholar 

  24. Nacamura T, Uramura K, Nambu T, et al. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res. 2000;873:181–7.

    Article  Google Scholar 

  25. Wu MF, John J, Maidment N, Lam HA, Siegel JM. Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am J Physiol Regul Integr Comp Physiol. 2002;283:R1079–86.

    PubMed  Google Scholar 

  26. Torterolo P, Yamuy J, Sampogna S, Morales FR, Chase MH. Hypocretinergic neurons are primarily involved in activation of the somatomotor system. Sleep. 2003;26:25–30.

    PubMed  Google Scholar 

  27. Allen R, Mignot E, Ripley B, Hishino S, Early C. Increased CSF hypocretin (orexin) in idiopathic restless legs syndrome. Neurology. 2002;59:639–41.

    Article  PubMed  CAS  Google Scholar 

  28. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol. 2001;18:128–47.

    Article  PubMed  CAS  Google Scholar 

  29. Stiasny-Kolster K, Mignot E, Ling L, Möller JC, Cassel W, Oertel WH. CSF hypocretin-1 levels in restless legs syndrome. Neurology. 2003;61(10):1426–9.

    Article  PubMed  CAS  Google Scholar 

  30. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002;59:1553–62.

    Article  PubMed  Google Scholar 

  31. Poceta JS, Parsons L, Engelland S, Kripke DF. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson’s disease. Sleep Med. 2009;10(1):129–33.

    Article  PubMed  Google Scholar 

  32. Bahammam A. Periodic leg movements in narcolepsy patients: impact on sleep architecture. Acta Neurol Scand. 2007;115:351–5.

    Article  PubMed  CAS  Google Scholar 

  33. Dauvilliers Y, Pennestri MH, Petit D, Dang-Vu T, Lavigne G, Montplaisir J. Periodic leg movements during sleep and wakefulness in narcolepsy. J Sleep Res. 2007;16:333–9.

    Article  PubMed  Google Scholar 

  34. Baker TL, Guilleminault C, Nino-Murcia G, Dement WC. Comparative polysomnographic study of narcolepsy and idiopathic central nervous system hypersomnia. Sleep. 1986;9:232–42.

    PubMed  CAS  Google Scholar 

  35. Okura M, Fujiki N, Ripley B, et al. Narcoleptic canines display periodic leg movements during sleep. Psychiat Clin Neurosci. 2001;55:243–4.

    Article  CAS  Google Scholar 

  36. Harsh J, Peszka J, Hartwig G, Mitler M. Night-time sleep and daytime sleepiness in narcolepsy. J Sleep Res. 2000;9:309–16.

    Article  PubMed  CAS  Google Scholar 

  37. Dauvilliers Y, Billiard M, Montplaisir J. Clinical aspects and pathophysiology of narcolepsy. Clin Neurophysiol. 2003;114:2000–17.

    Article  PubMed  Google Scholar 

  38. Scofield H, Roth T, Drake C. Periodic limb movements during sleep: population prevalence, clinical correlates, and racial differences. Sleep. 2008;31(9):1221–7.

    PubMed  Google Scholar 

  39. Ferri R, Zucconi M, Manconi M, Bruni O, Ferini-Strambi L, et al. Different periodicity and time structure of leg movements during sleep in narcolepsy/cataplexy and restless legs syndrome. Sleep. 2006;29:1587–94.

    PubMed  Google Scholar 

  40. Ferri R, Miano S, Bruni O, et al. NREM sleep alterations in narcolepsy/cataplexy. Clin Neurophysiol. 2005;116:2675–84.

    Article  PubMed  Google Scholar 

  41. Sforza E, Nicolas A, Lavigne G, Gosselin A, Petit D, et al. EEG and cardiac activation during periodic leg movements in sleep. Neurology. 1999;52:786–91.

    Article  PubMed  CAS  Google Scholar 

  42. Boivin DB, Montplaisir J, Poirier G. The effects of L-dopa on periodic leg movements and sleep organization in narcolepsy. Clin Neuropharmacol. 1989;12(4):339–45.

    Article  PubMed  CAS  Google Scholar 

  43. Boivin DB, Lorrain D, Montplaisir J. Effects of bromocriptine on periodic limb movements in human narcolepsy. Neurology. 1993;43:2134–6.

    Article  PubMed  CAS  Google Scholar 

  44. Bédard MA, Montplaisir J, Godbout R, Lapierre O. Nocturnal gamma-hydroxybutyrate. Effect on periodic leg movements and sleep organization of narcoleptic patients. Clin Neuropharmacol. 1989;12(1):29–36.

    Article  PubMed  Google Scholar 

  45. Abril B, Carlander B, Touchon J, Dauvilliers Y. Restless legs syndrome in narcolepsy: a side effect of sodium oxybate? Sleep Med. 2007;8:181–3.

    Article  PubMed  Google Scholar 

  46. Maitre M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol. 1997;51:337–61.

    Article  PubMed  CAS  Google Scholar 

  47. Roth T. Narcolepsy: treatment issues. J Clin Psychiatry. 2007;68 Suppl 13:16–9.

    PubMed  CAS  Google Scholar 

  48. Rottach K, Schaner B, Kirch M, et al. Restless legs syndrome as a side effect of second generation antidepressants. J Psychiat Res. 2009;43:70–5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luigi Ferini-Strambi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ferini-Strambi, L. (2011). The Motor System and Narcolepsy: Periodic Leg Movements and Restless Legs Syndrome. In: Baumann, C., Bassetti, C., Scammell, T. (eds) Narcolepsy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-8390-9_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-8390-9_28

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-8389-3

  • Online ISBN: 978-1-4419-8390-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics